Clinical Trial Update: Study to Determine Maximum Tolerated Dose of LErafAON Combined With Radiotherapy in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study to determine the maximum tolerated dose of LErafAON when given with radiotherapy in patients with advanced malignancies; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• LErafAON

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Neoplasms | Phase 1 | Status: COMPLETED